The Vermont Cancer Center (VCC), in Burlington, Vermont, is a matrix- based cancer center located on the campus of the University of Vermont. It is closely tied to the University of Vermont College of Medicine. Since its founding in 1974, the Vermont Cancer Center has been committed to its mission in research, education and service to the people of the Vermont and their neighbors in northern New York. Although it is the smallest NCI-designated Comprehensive Cancer Center, its central role in the UVM College of Medicine and the unusual nature of the rural and relatively stable population it serves have created an ideal environment for integration of basic, clinical and population-directed research related to cancer. After a period of aggressive reorganization within the Institution and within the Cancer Center it self, this CCSG renewal application reflects the diverse strengths of the Center in a substantially changed organizational and programmatic format. Four Research Programs are presented. Two are strongly grounded in basic research (1-Genome Stability and Expression Research Program; 2-Cell Signalling and Growth Control Research Program) but have clear links to cancer as a disease through studies at the 1) molecular/mechanistic, or 2) the cellular/biological level. A reorganized Clinical Research Program has a strong clinical/translation focus with both laboratory- and clinic-based research studies. Finally, the Center's Cancer Prevention and Control Research Program focuses on problems of major significance in the region served by the Center and includes a new emphasis on population-based studies of familial cancer predisposition. Seven Shared Resources or Support Services are presented, including two that are new to the Center and several that have been reorganized. These include: Biostatistics and Biometry Shared Resource, Bioanalytical Shared Resource, DNA Analysis Shared Resource, Cell Imaging Facility Shared Resource, Molecular Modeling Shared Resource, the Clinical Research Management shared Resource, and the Clinical Research Protocol Support Service. Developmental funds for pilot studies and recruitment of investigators critical to the Center's research mission are also requested.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Vermont & St Agric College
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Kelemen, Linda E; Abbott, Sarah; Qin, Bo et al. (2017) Cigarette smoking and the association with serous ovarian cancer in African American women: African American Cancer Epidemiology Study (AACES). Cancer Causes Control 28:699-708
Long, Patrick M; Tighe, Scott W; Driscoll, Heather E et al. (2015) Acetate supplementation as a means of inducing glioblastoma stem-like cell growth arrest. J Cell Physiol 230:1929-43
Tsen, Andrew R; Long, Patrick M; Driscoll, Heather E et al. (2014) Triacetin-based acetate supplementation as a chemotherapeutic adjuvant therapy in glioma. Int J Cancer 134:1300-10
Wagner, Darcy E; Bonenfant, Nicholas R; Parsons, Charles S et al. (2014) Comparative decellularization and recellularization of normal versus emphysematous human lungs. Biomaterials 35:3281-97
Long, Patrick M; Tighe, Scott W; Driscoll, Heather E et al. (2013) Acetate supplementation induces growth arrest of NG2/PDGFR?-positive oligodendroglioma-derived tumor-initiating cells. PLoS One 8:e80714
Sokocevic, Dino; Bonenfant, Nicholas R; Wagner, Darcy E et al. (2013) The effect of age and emphysematous and fibrotic injury on the re-cellularization of de-cellularized lungs. Biomaterials 34:3256-69
Long, Patrick M; Moffett, John R; Namboodiri, Aryan M A et al. (2013) N-acetylaspartate (NAA) and N-acetylaspartylglutamate (NAAG) promote growth and inhibit differentiation of glioma stem-like cells. J Biol Chem 288:26188-200
Bonenfant, Nicholas R; Sokocevic, Dino; Wagner, Darcy E et al. (2013) The effects of storage and sterilization on de-cellularized and re-cellularized whole lung. Biomaterials 34:3231-45
Murray, Janet M; Messier, Terri; Rivers, Jami et al. (2012) VDJ recombinase-mediated TCR ? locus gene usage and coding joint processing in peripheral T cells during perinatal and pediatric development. J Immunol 189:2356-64
Wallis, John M; Borg, Zachary D; Daly, Amanda B et al. (2012) Comparative assessment of detergent-based protocols for mouse lung de-cellularization and re-cellularization. Tissue Eng Part C Methods 18:420-32

Showing the most recent 10 out of 219 publications